期刊文献+

原发性肾透明细胞癌根治术患者预后与CD99基因表达的关系及预后影响因素分析

Relationship between prognosis of patients with primary clear cell renal cell carcinoma after radical nephrectomy and expression of CD99 and analysis of prognostic factors
下载PDF
导出
摘要 目的探讨影响原发性肾透明细胞癌(clear cell renal cell carcinoma,ccRCC)根治术患者的预后与肿瘤转移相关基因CD99的关系及预后的影响因素。方法应用半定量RT-PCR技术研究CD99基因在ccRCC组织和癌旁组织中的表达,通过随访调查患者的预后、生存时间及其危险因素,应用Cox风险回归模型分析获得影响预后的主要危险因素。结果与对应癌旁组织相比,CD99基因在ccRCC组织中表达上调的占73.5%,差异有统计学意义(P=0.000)。应用Cox风险回归模型分析发现:ccRCC组织中CD99基因的高表达[HR=0.14,95%CI(0.01,2.15)]与根治术患者预后的生存时间无关;而患者年龄[HR=1.18,95%CI(1.01,1.38)]、TNM分期[HR=51.91,95%CI(4.31,625.87)]、合并糖尿病[HR=59.94,95%CI(2.21,1 627)]和合并高血压[HR=47.72,95%CI(1.37,1 670)]是影响患者预后生存时间的主要危险因素。比较TNMⅠ期和Ⅱ~Ⅳ期两组患者的1年生存率和2年生存率(100.0%vs 60.0%,P=0.004;93.8%vs 8.3%,P=0.000),差异有统计学意义。结论肿瘤转移相关基因CD99的表达可能与ccRCC的预后无关,年龄、TNM分期、合并糖尿病和合并高血压是影响患者预后生存时间的主要危险因素。 Objective To investigate the relationship between prognosis of patients with primary clear cell renal cell carcinoma(ccRCC) after radical nephrectomy and expression of tumor metastasis-associated gene CD99 and to analyze the prognostic factors of ccRCC patients.Methods Semi-quantitative reverse transcription-polymerase chain reaction(RT-PCR) was used to examine the expression of CD99 in primary ccRCC tissues and their corresponding adjacent tissues.The prognosis and risk factors of survival time of patients were studied by follow-up investigation,and the main risk factors were screened by Cox hazard regression model.Results Compared with the adjacent renal tissues,73.5% ccRCC tissues had up-regulated CD99 expression,with significant difference found between the two groups(P=0.000).Cox hazard regression model showed that high CD99 expression in ccRCC tissues was not a survival risk factor of ccRCC patients after radical nephrectomy (HR=0.14,95%CI[0.01,2.15]);and age (HR= 1.18,95%CI[1.01,1.38]),TNM stages (HR=51.91,95%CI[4.31,625.87]),diabetes (HR=59.94,95%CI[2.21,1 627]) and hypertension (HR=47.72,95%CI[1.37,1 670]) were the major risk factors for the survival of patients after radical nephrectomy.The 1-year and 2-year survival rates of ccRCC patients in TNM stage Ⅰ were significantly higher than those in TNM stage Ⅱ-Ⅳ,respectively(100.0% vs 60.0%,P=0.004;93.8% vs 8.3%,P=0.000).Conclusion The expression of tumor metastasis-related gene CD99 may not be associated with the prognoses of ccRCC patients.Age,TNM stage,diabetes and hypertension are the major risk factors of prognosis after resection of ccRCC.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2011年第5期517-520,共4页 Academic Journal of Second Military Medical University
基金 上海市宝山区科学技术委员会基金(09-E-10)~~
关键词 CD99 基因表达 肾肿瘤 透明细胞癌 预后 CD99 gene expression kidney neoplasms clear cell carcinoma prognosis
  • 相关文献

参考文献17

  • 1Cohen H T,McGovern F J. Renal cell careinoma[J]. N Engl J Med,2005,353:2477- 2490.
  • 2Garcia J A,Rini B I. Recent progress in the management of ad- vanced renal cell carcinoma[J]. CA Cancer J Clin, 2007,57 : 112- 125.
  • 3Liou L S,Shi T,Duan Z H,Sadb.ukhan P,Der S D,Novick A A, et al. Microarray gene expression profiling and analysis in renal cell carcinoma[J]. BMC Urol, 2004,4 : 9.
  • 4Kim S P,AIt A L,Weight C J,Costello B A,Cheville J C,Lohse C,et al. Independent Validation of the 2010 American Joint Committee on Cancer TNM Classification for Renal Cell Carci noma: Results From a Large, Single Institution Cohort [J]. J Urol,2011. [ Epub ahead of print].
  • 5Kiatte T,Patard J J,de Martino M,Bensalah K,Verhoest G,de la Taille A,et al. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas[J]. J Urol, 2008,179:1719 -1726.
  • 6Lee J H,Kim S H,Wang L H,Choi Y L,Kim Y C,Kim J H,et al. Clinical significance of CD99 down regulation in gastric ade -nocarcinoma[J]. Clin Cancer Res, 2007,13 : 2584- 2591.
  • 7Bernard G, Zoccola D, Deckert M, Breittmayer J P, Aussel C Bernard A. The E2 molecule (CD99) specifically triggers homo- typic aggregation of CD4^+ CD8^+ thymoeytes. [J]. J Immunol 1995,154:26- 32.
  • 8Kim S H,Choi E Y,Shin Y K,Kim T J,Chung D H,Chang S I, et al. Generation of cells with Hodgkin's and Reed- Sternberg phenotype through downregulation of CD99 (Mic2)[J]. Blood, 1998,92:4287-4295.
  • 9Bernard G, Breittmayer J P, de Matteis M, Trampont P, Hof- man P,Senik A,et al. Apoptosis of immature thymoeytes medi- ated by E2/CD99[J]. J Immunol, 1997,158:2543- 2550.
  • 10Tan X, Zhai Y, Chang W, Hou J, He S, Lin L, et al. Global anal- ysis of metastasis associated gene expression in primary cul- tures from clinical specimens of clear-cell renal-cell carcinoma [J]. Int J Cancer,2008,123:1080- 1088.

二级参考文献33

  • 1Tan X,Zhai Y,Chang W,Hou J,He S,Lin L,et al. Global analysis of metastasis-associated gene expression in primary cultures from clinical specimens of cleavcell renal cell carcinoma [J].Int J Cancer,2008,123:1080-1088.
  • 2Lee J H, Kim S H, Wang L H, Choi Y L, Kim Y C, Kim J H, et al. Clinical significance of CD99 down-regulation in gastric adenocarcinoma[J]. Clin Cancer Res, 2007,13:2584-2591.
  • 3Bernard G, Zoccola D, Deckert M, Breittmayer J P, Aussel C Bernard A. The E2 molecule (CD99) specifically triggers homotypic aggregation of CD4^+ CD8^+ thymocytes[J]. J Immunol, 1995,154:26-32.
  • 4Kim S H, Choi E Y, Shin Y K, Kim T J, Chung D H, Chang S I,et al. Generation of cells with Hodgkin's and Reed-Sternberg phenotype through downregulation of CD99 (Mie2)[J]. Blood,1998,92:4287-4295.
  • 5Bernard G, Breittmayer J P, de Matteis M, Trampont P, Hofman P, Senik A,et al. Apoptosis of immature thymoeytes mediated by E2/ CD99[J]. J Immunol,1997,158:2543-2550.
  • 6Scotlandi K, Zuntini M, Manara M C, Sciandra M, Rocchi A,Benini S, et al. CD99 isoforms dictate opposite functions in tumoor malignancy and metastases by activating or repressing c-Src kinase activity[J]. Oncogene, 2007,26:6604-6618.
  • 7Ellis N A, Ye T Z, Patton S, German J, Goodfellow P N, Weller P. Cloning of PBDX, an MIC2-related gene that spans the pseudoautosomal boundary on chromosome Xp[J]. Nat Genet, 1994,6 : 394-400.
  • 8Kim E, Lee H J, Hahn J H, Park S H, Lee H. Expression of a spliced variant of CD99 membrane protein increases motility, matrix degradation, and invasiveness of human breast carcinoma cells[J]. Proc Amer Assoc Cancer Res,2000,41:231-232.
  • 9Byun H J, Hong I K, KimE, Jin Y J, Jeoung D I, HahnJ H, et al. A splice variant of CD99 increases motility and MMP-9 expression of human breast cancer cells through the AKT , ERK-, and JNK-dependent AP-1 activation signaling pathways [J]. J Biol Chem, 2006,281 : 34.833-34847.
  • 10Mickisch G, Carballido J, Hellsten S, Schulze H, Mensink H, European Association of Urology. Guidelines on renal cell cancer[J]. Eur Urol, 2001,40:252-255.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部